PaxMedica Management

Management criteria checks 2/4

PaxMedica's CEO is Howard Weisman, appointed in Mar 2020, has a tenure of 4.25 years. total yearly compensation is $1.05M, comprised of 45.5% salary and 54.5% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $11.47K. The average tenure of the management team and the board of directors is 1.9 years and 3 years respectively.

Key information

Howard Weisman

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage45.5%
CEO tenure4.3yrs
CEO ownership0.4%
Management average tenure1.9yrs
Board average tenure3yrs

Recent management updates

Recent updates

PaxMedica to debut on Nasdaq after pricing scaled-down $8.1M IPO

Aug 26

CEO Compensation Analysis

How has Howard Weisman's remuneration changed compared to PaxMedica's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$1mUS$478k

-US$18m

Sep 30 2023n/an/a

-US$18m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$4mUS$400k

-US$15m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$558kUS$400k

-US$10m

Compensation vs Market: Howard's total compensation ($USD1.05M) is above average for companies of similar size in the US market ($USD665.80K).

Compensation vs Earnings: Howard's compensation has been consistent with company performance over the past year.


CEO

Howard Weisman (64 yo)

4.3yrs

Tenure

US$1,050,224

Compensation

Mr. Howard J. Weisman has been the Chief Executive Officer and Director of PaxMedica Inc. since March 2020 and serves as its Chairman since August 21, 2023. Prior to joining PaxMedica, from September 2016...


Leadership Team

NamePositionTenureCompensationOwnership
Howard Weisman
CEO & Chairman4.3yrsUS$1.05m0.45%
$ 11.5k
Stephen Sheldon
CFO & COO1.9yrsUS$635.87k0.032%
$ 815.4
David Hough
Chief Medical Officerless than a yearUS$266.78k0.076%
$ 1.9k

1.9yrs

Average Tenure

64yo

Average Age

Experienced Management: PXMD's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Howard Weisman
CEO & Chairman4.3yrsUS$1.05m0.45%
$ 11.5k
Charles Casamento
Lead Independent Director1.7yrsUS$98.83k0.0019%
$ 50.1
Stefan K. Schwabe
Member of Scientific Advisory Boardless than a yearno datano data
Reymundo Lozano
Member of Advisory Boardno datano datano data
Karen LaRochelle
Independent Director3.9yrsUS$83.31k0.029%
$ 744.7
Michael Aman
Member of Scientific Advisory Boardno datano datano data
Zachary Rome
Director5.3yrsUS$358.28k0.13%
$ 3.4k
Constance Smith-Hicks
Member of Scientific Advisory Boardno datano datano data
Alice Mao
Member of Scientific Advisory Boardno datano datano data
John Coelho
Independent Director2.1yrsUS$79.47k0.057%
$ 1.5k
Veronica Martinez Cerdeno
Member of Advisory Boardno datano datano data
Robert Naviaux
Member of Scientific Advisory Boardno datano datano data

3.0yrs

Average Tenure

60yo

Average Age

Experienced Board: PXMD's board of directors are considered experienced (3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.